Evolent Health, Inc.EVHNYSE
Loading
EBITDA Margin Over TimeContracting
Percentile Rank46
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Percentile
P46
Within normal range
vs 3Y Ago
-6x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM-19.26%-679.8%
20243.32%+363.2%
2023-1.26%-139.0%
20223.24%-47.2%
20216.13%+123.5%
2020-26.04%+29.7%
2019-37.04%-5494.3%
2018-0.66%+92.9%
2017-9.29%+89.3%
2016-86.67%-